single-organism process (GO:0044699) | 0.48 | 12 | CHD8, TMLHE, SLC9A9, SHANK2, MET, NLGN4X, MECP2, EN2, NLGN3, RPL10, EIF4E, CNTNAP2 |
cellular process (GO:0009987) | 0.26 | 11 | CHD8, TMLHE, SHANK2, MET, NLGN4X, MECP2, EN2, NLGN3, RPL10, EIF4E, CNTNAP2 |
biological regulation (GO:0065007) | 0.39 | 11 | CHD8, TMLHE, SLC9A9, MET, PTCHD1, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E |
multicellular organismal process (GO:0032501) | 1.45 | 10 | CHD8, MET, PTCHD1, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E, CNTNAP2 |
regulation of biological process (GO:0050789) | 0.45 | 10 | CHD8, TMLHE, MET, PTCHD1, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E |
negative regulation of biological process (GO:0048519) | 1.33 | 9 | CHD8, TMLHE, MET, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E |
single-multicellular organism process (GO:0044707) | 1.78 | 9 | CHD8, MET, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E, CNTNAP2 |
regulation of cellular process (GO:0050794) | 0.5 | 9 | CHD8, MET, PTCHD1, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E |
developmental process (GO:0032502) | 1.36 | 8 | CHD8, MET, NLGN4X, MECP2, EN2, NLGN3, EIF4E, CNTNAP2 |
cellular component organization (GO:0016043) | 1.24 | 8 | CHD8, SHANK2, MET, NLGN4X, MECP2, NLGN3, RPL10, CNTNAP2 |
single-organism developmental process (GO:0044767) | 1.49 | 8 | CHD8, MET, NLGN4X, MECP2, EN2, NLGN3, EIF4E, CNTNAP2 |
single-organism cellular process (GO:0044763) | 0.65 | 8 | NLGN4X, SHANK2, MET, MECP2, EN2, NLGN3, RPL10, CNTNAP2 |
negative regulation of cellular process (GO:0048523) | 1.41 | 8 | CHD8, MET, NLGN4X, MECP2, EN2, NLGN3, SHANK2, EIF4E |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 8 | CHD8, SHANK2, MET, NLGN4X, MECP2, NLGN3, RPL10, CNTNAP2 |
positive regulation of biological process (GO:0048518) | 1.2 | 7 | CHD8, MET, MECP2, EN2, NLGN3, SHANK2, EIF4E |
positive regulation of cellular process (GO:0048522) | 1.3 | 7 | CHD8, MET, MECP2, EN2, NLGN3, SHANK2, EIF4E |
regulation of metabolic process (GO:0019222) | 1.02 | 6 | CHD8, TMLHE, MET, MECP2, EN2, EIF4E |
neurological system process (GO:0050877) | 2.64 | 6 | NLGN4X, PTCHD1, MECP2, NLGN3, SHANK2, CNTNAP2 |
anatomical structure development (GO:0048856) | 1.58 | 6 | CHD8, NLGN4X, MECP2, EN2, EIF4E, CNTNAP2 |
cognition (GO:0050890) | 4.2 | 6 | NLGN4X, PTCHD1, MECP2, NLGN3, SHANK2, CNTNAP2 |
behavior (GO:0007610) | 3.47 | 6 | NLGN4X, MECP2, NLGN3, SHANK2, EIF4E, CNTNAP2 |
organic substance metabolic process (GO:0071704) | 0.63 | 6 | CHD8, TMLHE, MET, RPL10, MECP2, EIF4E |
cellular metabolic process (GO:0044237) | 0.69 | 6 | CHD8, TMLHE, MET, RPL10, MECP2, EIF4E |
metabolic process (GO:0008152) | 0.58 | 6 | CHD8, TMLHE, MET, RPL10, MECP2, EIF4E |
single-organism behavior (GO:0044708) | 3.79 | 6 | NLGN4X, MECP2, NLGN3, SHANK2, EIF4E, CNTNAP2 |
system process (GO:0003008) | 2.3 | 6 | NLGN4X, PTCHD1, MECP2, NLGN3, SHANK2, CNTNAP2 |
localization (GO:0051179) | 1.4 | 6 | SLC9A9, RPL10, NLGN3, MECP2, EIF4E, CNTNAP2 |
multi-organism process (GO:0051704) | 2.65 | 6 | NLGN4X, MECP2, NLGN3, SHANK2, EIF4E, CNTNAP2 |
cellular component assembly (GO:0022607) | 2.14 | 5 | NLGN4X, NLGN3, RPL10, MECP2, SHANK2 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 5 | MET, MECP2, CHD8, EN2, EIF4E |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
learning (GO:0007612) | 4.85 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
learning or memory (GO:0007611) | 4.33 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
cellular biosynthetic process (GO:0044249) | 1.37 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
regulation of signaling (GO:0023051) | 1.72 | 5 | CHD8, NLGN3, NLGN4X, MECP2, SHANK2 |
regulation of cell communication (GO:0010646) | 1.73 | 5 | CHD8, NLGN3, NLGN4X, MECP2, SHANK2 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 5 | MET, CHD8, RPL10, MECP2, EIF4E |
cellular developmental process (GO:0048869) | 1.82 | 5 | MET, EN2, NLGN3, NLGN4X, MECP2 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
animal organ development (GO:0048513) | 2.53 | 5 | CNTNAP2, CHD8, EN2, MECP2, EIF4E |
regulation of biological quality (GO:0065008) | 1.68 | 5 | NLGN4X, NLGN3, SHANK2, MECP2, SLC9A9 |
regulation of gene expression (GO:0010468) | 1.37 | 5 | EN2, MET, CHD8, MECP2, EIF4E |
primary metabolic process (GO:0044238) | 0.69 | 5 | MET, CHD8, RPL10, MECP2, EIF4E |
social behavior (GO:0035176) | 5.9 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
transport (GO:0006810) | 1.51 | 5 | RPL10, NLGN3, MECP2, EIF4E, SLC9A9 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 5 | EN2, MET, CHD8, MECP2, EIF4E |
biosynthetic process (GO:0009058) | 1.32 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
intraspecies interaction between organisms (GO:0051703) | 5.9 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
establishment of localization (GO:0051234) | 1.48 | 5 | RPL10, NLGN3, MECP2, EIF4E, SLC9A9 |
multi-organism behavior (GO:0051705) | 5.6 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
adult behavior (GO:0030534) | 4.79 | 5 | CNTNAP2, NLGN4X, NLGN3, SHANK2, MECP2 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 5 | CHD8, RPL10, TMLHE, MECP2, EIF4E |
macromolecule metabolic process (GO:0043170) | 0.83 | 5 | MET, CHD8, RPL10, MECP2, EIF4E |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 5 | MET, EN2, MECP2, EIF4E, CHD8 |
synapse organization (GO:0050808) | 4.87 | 4 | NLGN4X, NLGN3, SHANK2, MECP2 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 4 | CHD8, TMLHE, MECP2, EIF4E |
positive regulation of metabolic process (GO:0009893) | 1.74 | 4 | MET, CHD8, EN2, MECP2 |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | MET, CHD8, EN2, MECP2 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 4 | MET, NLGN4X, NLGN3, CHD8 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 4 | MET, EN2, CHD8, MECP2 |
regulation of response to stimulus (GO:0048583) | 1.54 | 4 | MET, NLGN4X, NLGN3, CHD8 |
modulation of synaptic transmission (GO:0050804) | 4.09 | 4 | NLGN4X, NLGN3, SHANK2, MECP2 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 4 | CHD8, RPL10, MECP2, EIF4E |
negative regulation of signaling (GO:0023057) | 2.65 | 4 | CHD8, NLGN3, NLGN4X, SHANK2 |
positive regulation of gene expression (GO:0010628) | 2.35 | 4 | MET, EN2, CHD8, MECP2 |
negative regulation of cell communication (GO:0010648) | 2.66 | 4 | CHD8, NLGN3, NLGN4X, SHANK2 |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 4 | CHD8, RPL10, MECP2, EIF4E |
regulation of cell death (GO:0010941) | 2.43 | 4 | MET, CHD8, EN2, MECP2 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 4 | CHD8, RPL10, MECP2, EIF4E |
cellular protein metabolic process (GO:0044267) | 1.63 | 4 | MET, RPL10, MECP2, EIF4E |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 4 | MET, CHD8, EN2, MECP2 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | MET, EN2, CHD8, MECP2 |
regulation of programmed cell death (GO:0043067) | 2.49 | 4 | MET, EN2, CHD8, MECP2 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 4 | MET, EN2, CHD8, MECP2 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 4 | MET, CHD8, EN2, MECP2 |
vocalization behavior (GO:0071625) | 7.09 | 4 | CNTNAP2, NLGN4X, NLGN3, SHANK2 |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 4 | MET, EN2, CHD8, MECP2 |
cell differentiation (GO:0030154) | 2.14 | 4 | NLGN4X, NLGN3, EN2, MECP2 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 4 | MET, EN2, CHD8, MECP2 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 4 | CHD8, RPL10, MECP2, EIF4E |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 4 | MET, CHD8, EN2, MECP2 |
negative regulation of cell death (GO:0060548) | 2.95 | 4 | MET, EN2, CHD8, MECP2 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 4 | CHD8, RPL10, MECP2, EIF4E |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 4 | MET, EN2, CHD8, MECP2 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 4 | CHD8, RPL10, MECP2, EIF4E |
single-organism membrane organization (GO:0044802) | 3.19 | 4 | CNTNAP2, NLGN4X, NLGN3, RPL10 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 4 | MET, CHD8, EN2, MECP2 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 4 | MET, NLGN3, MECP2, EIF4E |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 4 | MET, EN2, CHD8, MECP2 |
heterocycle metabolic process (GO:0046483) | 1.31 | 4 | CHD8, RPL10, MECP2, EIF4E |
RNA metabolic process (GO:0016070) | 1.59 | 4 | CHD8, RPL10, MECP2, EIF4E |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 4 | RPL10, TMLHE, MECP2, EIF4E |
membrane organization (GO:0061024) | 3.04 | 4 | CNTNAP2, NLGN4X, NLGN3, RPL10 |
protein metabolic process (GO:0019538) | 1.45 | 4 | MET, RPL10, MECP2, EIF4E |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 4 | MET, CHD8, EN2, MECP2 |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 4 | MET, CHD8, EN2, MECP2 |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 4 | MET, EN2, CHD8, MECP2 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 4 | MET, CHD8, EN2, MECP2 |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 4 | MET, EN2, CHD8, MECP2 |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 4 | MET, EN2, CHD8, MECP2 |
regulation of membrane potential (GO:0042391) | 3.89 | 3 | NLGN4X, NLGN3, MECP2 |
protein localization (GO:0008104) | 2.36 | 3 | CNTNAP2, RPL10, MECP2 |
RNA biosynthetic process (GO:0032774) | 1.84 | 3 | CHD8, RPL10, MECP2 |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 3 | CHD8, MECP2, EIF4E |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | CHD8, RPL10, MECP2 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | CHD8, MECP2, EIF4E |
positive regulation of synaptic transmission (GO:0050806) | 5.07 | 3 | NLGN3, SHANK2, MECP2 |
negative regulation of synaptic transmission (GO:0050805) | 5.67 | 3 | NLGN4X, NLGN3, SHANK2 |
positive regulation of signaling (GO:0023056) | 2.41 | 3 | NLGN3, SHANK2, MECP2 |
cell adhesion (GO:0007155) | 2.82 | 3 | CNTNAP2, NLGN4X, NLGN3 |
negative regulation of gene expression (GO:0010629) | 2.48 | 3 | CHD8, MECP2, EIF4E |
regulation of cell development (GO:0060284) | 3.01 | 3 | NLGN3, MECP2, EIF4E |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 3 | MET, CHD8, PTCHD1 |
regulation of cell differentiation (GO:0045595) | 2.42 | 3 | NLGN3, MECP2, EIF4E |
positive regulation of cell communication (GO:0010647) | 2.41 | 3 | NLGN3, SHANK2, MECP2 |
regulation of apoptotic process (GO:0042981) | 2.5 | 3 | CHD8, EN2, MECP2 |
synapse assembly (GO:0007416) | 5.55 | 3 | NLGN3, SHANK2, MECP2 |
regulation of neurogenesis (GO:0050767) | 3.21 | 3 | NLGN3, MECP2, EIF4E |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | CHD8, MECP2, EIF4E |
negative regulation of signal transduction (GO:0009968) | 2.75 | 3 | CHD8, NLGN3, NLGN4X |
regulation of signal transduction (GO:0009966) | 1.84 | 3 | CHD8, NLGN3, NLGN4X |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | CHD8, RPL10, MECP2 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 3 | MET, NLGN3, MECP2 |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 3 | NLGN3, MECP2, EIF4E |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 3 | CHD8, MECP2, EIF4E |
negative regulation of neurogenesis (GO:0050768) | 4.22 | 3 | NLGN3, MECP2, EIF4E |
regulation of synapse structure or activity (GO:0050803) | 4.77 | 3 | NLGN3, SHANK2, MECP2 |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 3 | CHD8, MECP2, EIF4E |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 3 | CHD8, EN2, MECP2 |
negative regulation of cell development (GO:0010721) | 4.02 | 3 | NLGN3, MECP2, EIF4E |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 3 | MET, CHD8, EN2 |
macromolecule localization (GO:0033036) | 2.34 | 3 | CNTNAP2, RPL10, MECP2 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | CHD8, RPL10, MECP2 |
neuron differentiation (GO:0030182) | 4.17 | 3 | EN2, NLGN4X, MECP2 |
regulation of developmental process (GO:0050793) | 2.1 | 3 | NLGN3, MECP2, EIF4E |
organic substance transport (GO:0071702) | 2.15 | 3 | RPL10, MECP2, EIF4E |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 3 | NLGN3, MECP2, EIF4E |
single-organism transport (GO:0044765) | 2.18 | 3 | RPL10, MECP2, SLC9A9 |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 3 | CHD8, MECP2, EIF4E |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 3 | CHD8, RPL10, MECP2 |
single-organism localization (GO:1902578) | 2.09 | 3 | RPL10, MECP2, SLC9A9 |
cellular localization (GO:0051641) | 2.32 | 3 | CNTNAP2, RPL10, EIF4E |
negative regulation of developmental process (GO:0051093) | 3.17 | 3 | NLGN3, MECP2, EIF4E |
biological adhesion (GO:0022610) | 2.81 | 3 | CNTNAP2, NLGN4X, NLGN3 |
brain development (GO:0007420) | 4.24 | 3 | CNTNAP2, CHD8, MECP2 |
organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 3 | TMLHE, RPL10, EIF4E |
long-term synaptic potentiation (GO:0060291) | 6.07 | 3 | NLGN3, SHANK2, MECP2 |
response to stimulus (GO:0050896) | 1.22 | 3 | NLGN3, MECP2, EIF4E |
regulation of synaptic plasticity (GO:0048167) | 4.78 | 3 | NLGN3, SHANK2, MECP2 |
negative regulation of nervous system development (GO:0051961) | 4.15 | 3 | NLGN3, MECP2, EIF4E |
regulation of nervous system development (GO:0051960) | 3.1 | 3 | NLGN3, MECP2, EIF4E |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | NLGN3, MECP2, EIF4E |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | CHD8, RPL10, MECP2 |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 3 | CHD8, MECP2, EIF4E |
signal transduction (GO:0007165) | 1.28 | 3 | MET, PTCHD1, CHD8 |
developmental growth (GO:0048589) | 4.05 | 2 | NLGN4X, NLGN3 |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | MET, NLGN3 |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 2 | EN2, MECP2 |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 2 | EN2, MECP2 |
organic cyclic compound catabolic process (GO:1901361) | 3.73 | 2 | RPL10, EIF4E |
single-organism metabolic process (GO:0044710) | 1.63 | 2 | TMLHE, MECP2 |
cellular macromolecule localization (GO:0070727) | 3.1 | 2 | CNTNAP2, RPL10 |
peptide biosynthetic process (GO:0043043) | 3.73 | 2 | RPL10, EIF4E |
presynaptic membrane assembly (GO:0097105) | 7.53 | 2 | NLGN4X, NLGN3 |
negative regulation of neuron differentiation (GO:0045665) | 4.45 | 2 | NLGN3, EIF4E |
regulation of neuron differentiation (GO:0045664) | 3.39 | 2 | NLGN3, EIF4E |
amide biosynthetic process (GO:0043604) | 3.6 | 2 | RPL10, EIF4E |
oxidation-reduction process (GO:0055114) | 2.91 | 2 | TMLHE, MECP2 |
single organism signaling (GO:0044700) | 3.25 | 2 | CNTNAP2, MECP2 |
multicellular organismal response to stress (GO:0033555) | 5.67 | 2 | MECP2, EIF4E |
aromatic compound catabolic process (GO:0019439) | 3.79 | 2 | RPL10, EIF4E |
signaling (GO:0023052) | 3.25 | 2 | CNTNAP2, MECP2 |
visual behavior (GO:0007632) | 5.82 | 2 | NLGN3, MECP2 |
presynaptic membrane organization (GO:0097090) | 7.43 | 2 | NLGN4X, NLGN3 |
neuron projection development (GO:0031175) | 4.58 | 2 | CNTNAP2, MECP2 |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 2 | CHD8, MECP2 |
organic substance catabolic process (GO:1901575) | 2.45 | 2 | RPL10, EIF4E |
cellular macromolecule catabolic process (GO:0044265) | 3.19 | 2 | RPL10, EIF4E |
behavioral defense response (GO:0002209) | 6.43 | 2 | MECP2, EIF4E |
regulation of molecular function (GO:0065009) | 1.78 | 2 | TMLHE, NLGN3 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | NLGN3, MECP2 |
single organism cell adhesion (GO:0098602) | 3.63 | 2 | NLGN4X, NLGN3 |
cell-cell adhesion (GO:0098609) | 3.34 | 2 | NLGN4X, NLGN3 |
heterocycle catabolic process (GO:0046700) | 3.82 | 2 | RPL10, EIF4E |
defense response (GO:0006952) | 2.78 | 2 | MECP2, EIF4E |
macromolecule modification (GO:0043412) | 1.73 | 2 | MET, MECP2 |
protein modification process (GO:0036211) | 1.79 | 2 | MET, MECP2 |
excitatory postsynaptic potential (GO:0060079) | 6.43 | 2 | NLGN3, MECP2 |
nucleobase-containing compound catabolic process (GO:0034655) | 3.9 | 2 | RPL10, EIF4E |
regulation of neuron death (GO:1901214) | 4.19 | 2 | EN2, MECP2 |
cerebellum development (GO:0021549) | 5.8 | 2 | NLGN4X, MECP2 |
mRNA metabolic process (GO:0016071) | 3.33 | 2 | RPL10, EIF4E |
cellular nitrogen compound catabolic process (GO:0044270) | 3.8 | 2 | RPL10, EIF4E |
intracellular transport (GO:0046907) | 2.67 | 2 | RPL10, EIF4E |
response to stress (GO:0006950) | 1.8 | 2 | MECP2, EIF4E |
regulation of synapse assembly (GO:0051963) | 5.36 | 2 | NLGN3, MECP2 |
positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | NLGN3, MECP2 |
associative learning (GO:0008306) | 5.44 | 2 | NLGN3, MECP2 |
transcription, DNA-templated (GO:0006351) | 1.91 | 2 | CHD8, MECP2 |
positive regulation of synapse assembly (GO:0051965) | 5.62 | 2 | NLGN3, MECP2 |
peptide metabolic process (GO:0006518) | 3.44 | 2 | RPL10, EIF4E |
response to radiation (GO:0009314) | 3.69 | 2 | NLGN3, MECP2 |
regulation of synapse organization (GO:0050807) | 5.03 | 2 | NLGN3, MECP2 |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | NLGN3, MECP2 |
regulation of cellular component organization (GO:0051128) | 2.01 | 2 | NLGN3, MECP2 |
cellular catabolic process (GO:0044248) | 2.62 | 2 | RPL10, EIF4E |
response to light stimulus (GO:0009416) | 4.08 | 2 | NLGN3, MECP2 |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 2 | MET, MECP2 |
regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 2 | NLGN3, MECP2 |
visual learning (GO:0008542) | 5.92 | 2 | NLGN3, MECP2 |
behavioral fear response (GO:0001662) | 6.43 | 2 | MECP2, EIF4E |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 2 | MECP2, EIF4E |
negative regulation of neuron death (GO:1901215) | 4.57 | 2 | EN2, MECP2 |
regulation of system process (GO:0044057) | 3.53 | 2 | NLGN3, MECP2 |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 2 | CHD8, MECP2 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | MECP2, EIF4E |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 2 | CHD8, MECP2 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 2 | CHD8, MECP2 |
regulation of localization (GO:0032879) | 1.94 | 2 | MET, NLGN3 |
regulation of respiratory gaseous exchange (GO:0043576) | 6.59 | 2 | NLGN3, MECP2 |
regulation of respiratory system process (GO:0044065) | 6.96 | 2 | NLGN3, MECP2 |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 2 | MECP2, EIF4E |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | MECP2, EIF4E |
cellular amide metabolic process (GO:0043603) | 3.23 | 2 | RPL10, EIF4E |
positive regulation of developmental process (GO:0051094) | 2.77 | 2 | NLGN3, MECP2 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 2 | CHD8, MECP2 |
modulation of excitatory postsynaptic potential (GO:0098815) | 6.33 | 2 | NLGN4X, NLGN3 |
nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.49 | 2 | RPL10, EIF4E |
system development (GO:0048731) | 2.92 | 2 | CNTNAP2, MECP2 |
single organismal cell-cell adhesion (GO:0016337) | 3.69 | 2 | NLGN4X, NLGN3 |
cell projection organization (GO:0030030) | 3.14 | 2 | CNTNAP2, MECP2 |
fear response (GO:0042596) | 6.36 | 2 | MECP2, EIF4E |
regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 7.16 | 2 | NLGN3, MECP2 |
multicellular organism development (GO:0007275) | 2.54 | 2 | CHD8, EN2 |
growth (GO:0040007) | 3.8 | 2 | NLGN4X, NLGN3 |
chromatin organization (GO:0006325) | 3.28 | 2 | CHD8, MECP2 |
nitrogen compound transport (GO:0071705) | 3.54 | 2 | MECP2, EIF4E |
RNA catabolic process (GO:0006401) | 4.3 | 2 | RPL10, EIF4E |
mRNA catabolic process (GO:0006402) | 4.43 | 2 | RPL10, EIF4E |
membrane assembly (GO:0071709) | 6.59 | 2 | NLGN4X, NLGN3 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | CHD8, MECP2 |
cellular protein localization (GO:0034613) | 3.11 | 2 | CNTNAP2, RPL10 |
cellular protein modification process (GO:0006464) | 1.79 | 2 | MET, MECP2 |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 2 | CHD8, MECP2 |
neuron cell-cell adhesion (GO:0007158) | 6.96 | 2 | NLGN4X, NLGN3 |
establishment of localization in cell (GO:0051649) | 2.47 | 2 | RPL10, EIF4E |
catabolic process (GO:0009056) | 2.38 | 2 | RPL10, EIF4E |
macromolecule catabolic process (GO:0009057) | 3.0 | 2 | RPL10, EIF4E |
response to abiotic stimulus (GO:0009628) | 2.8 | 2 | NLGN3, MECP2 |
negative regulation of excitatory postsynaptic potential (GO:0090394) | 7.53 | 2 | NLGN4X, NLGN3 |
regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | NLGN3, MECP2 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 2 | MET, MECP2 |
phosphorus metabolic process (GO:0006793) | 2.15 | 2 | MET, MECP2 |
translational initiation (GO:0006413) | 4.72 | 2 | RPL10, EIF4E |
translation (GO:0006412) | 3.79 | 2 | RPL10, EIF4E |
positive regulation of cellular component biogenesis (GO:0044089) | 3.71 | 2 | NLGN3, MECP2 |